- Valuation
- ₹9,801 Cr

About Balaji Amines
Balaji Amines is a publicly listed company based in Solapur (India) founded in 1988 by Ande Prathap Reddy. Diversified chemicals including methylamines and pharma excipients are manufactured. The company has 21 employees. Its Indian entity Balaji Amines Limited reported revenue of βΉ1,454 Cr. Balaji Amines offers products and services including Amines, Derivatives, Speciality Chemicals, and Pharma Excipients. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified.
Company details
Balaji Amines was established in 1988 and is headquartered in Solapur, India. Operations focus on the chemical manufacturing sector, where methylamines, ethylamines, derivatives of specialty chemicals, and pharmaceutical excipients are produced. Downstream products are developed for applications in the pharmaceutical and pesticides industries, supporting various industrial needs through diversified chemical outputs.
Recognitions & Rankings of Balaji Amines
- Headquarters Solapur, India
- Employees 21
- Founders Ande Prathap Reddy
- Stage Public
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website balajiamines.com
- Social LinkedIn
- Legal Name Balaji Amines Limited
- Market Cap₹5,758 Cr
BALAMINES · NSE
- Share Price₹1,796.70
+1.10% today
- Revenue₹1,425 Cr
FY 2025-26 · +2.0% YoY
- EBITDA₹265 Cr
Margin 18.6%
- Net Profit₹167 Cr
FY 2025-26 · +6.1% YoY
- P/E (TTM)24.1x
P/B 2.7x
- ROE8.8%
ROCE 11.9%
- Debt / Equity0.04
Interest cover 2.6x
- Employee Count21
Associated legal entities of Balaji Amines
Balaji Amines is associated with 2 registered companies on The Company Check; the primary company is Balaji Amines Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Balaji Amines Limited Listed CIN L24132MH1988PLC049387 | Active | 27 Oct 1988 | Solapur, Maharashtra | ₹1,454 Cr | 1,098 | 10 | View details |
| Balaji Speciality Fine Chem Products Llp CIN AAY-7521 | Active | 26 Sep 2021 | Solapur, Maharashtra | 2 | View details |
Products & Services of Balaji Amines
Balaji Amines offers a comprehensive portfolio of products and services, including Amines, Derivatives, Speciality Chemicals, and Pharma Excipients.
Manufacture of methylamines and ethylamines for industrial applications
Downstream products for pharma and pesticide sectors
Custom chemicals meeting user-specific requirements
Excipients for pharmaceutical formulations and processes
Board of directors of Balaji Amines Limited (Balaji Amines)
Balaji Amines Limited is the primary company behind Balaji Amines. The boards of the 2 registered companies of Balaji Amines currently have 8 directors; the longest-serving is Pratap Reddy Ande, appointed in 2013. 28 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pratap Reddy Ande DIN 00003967 | Whole-time director | 01 Apr 2013 | 13 yrs 7 mo | Balaji Amines Limited |
| Ande Srinivas Reddy DIN 03169721 | Whole-time director | 30 Sep 2013 | 13 yrs 1 mo | Balaji Amines Limited |
| Rajeshwar Reddy Nomula DIN 00003854 | Designated Partner | 26 Sep 2021 | 5 yrs 1 mo | Balaji Speciality Fine Chem Products Llp, Balaji Amines Limited |
| Ram Reddy Dundurapu DIN 00003864 | Designated Partner | 26 Sep 2021 | 5 yrs 1 mo | Balaji Speciality Fine Chem Products Llp, Balaji Amines Limited |
| Suhasini Yatin Shah DIN 02168705 | Director | 20 May 2023 | 3 yrs 5 mo | Balaji Amines Limited |
| Uma Rajiv Pradhan DIN 10096017 | Director | 20 May 2023 | 3 yrs 5 mo | Balaji Amines Limited |
| Mohan Kumar Ramakrishna DIN 10168247 | Director | 20 May 2023 | 3 yrs 5 mo | Balaji Amines Limited |
| Rao Seshagiri Adabala DIN 09608973 | Director | 20 May 2023 | 3 yrs 5 mo | Balaji Amines Limited |
People of Balaji Amines
1 people are tracked at Balaji Amines (1 in leadership); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
| Founder & Chairman | Leadership |
Complete people profiles for Balaji Amines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Balaji Amines
Balaji Amines is a publicly listed company on the NSE with ticker symbol BALAMINES in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Apr 2007
- Listed onNSE: BALAMINES
- Listed entityBalaji Amines Limited
- Exchange sectorProcess industries
- ISININE050E01027
- Share price₹2,078.60 (-0.26% on the day) · 2026-10-14
- Market capitalisation₹6,754 Cr
- Price to earnings33.0
- EPS (diluted, trailing year)₹63.00
- Dividend yield0.53%
- Volume (last session)104,815
Financials of Balaji Amines
Exchange-reported figures of Balaji Amines Limited, the listed company behind Balaji Amines (NSE: BALAMINES).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,425 | 1,397 | 1,642 | 2,355 | 2,323 | 1,311 | 936 |
| Revenue growth | +2.0% | -14.9% | -30.3% | +1.4% | +77.1% | +40.2% | - |
| EBITDA | 265 | 232 | 324 | 609 | 623 | 373 | 181 |
| EBITDA margin | +18.6% | +16.6% | +19.7% | +25.9% | +26.8% | +28.5% | +19.3% |
| Profit before tax | 232 | 213 | 302 | 567 | 578 | 327 | 131 |
| Net profit | 167 | 157 | 204 | 324 | 368 | 237 | 105 |
| Net profit margin | +11.7% | +11.3% | +12.5% | +13.7% | +15.9% | +18.1% | +11.2% |
| EPS (βΉ) | 51.60 | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 |
| Balance sheet | |||||||
| Total assets | 2,295 | 2,033 | 1,919 | 1,760 | 1,420 | 1,058 | 945 |
| Net worth | 1,976 | 1,845 | 1,722 | 1,554 | 1,250 | 894 | 658 |
| Total debt | 133 | 11.03 | 19.70 | 57.57 | 101 | 127 | 260 |
| Cash & bank | 271 | 354 | 340 | 236 | 51.56 | 19.64 | 8.81 |
| Net working capital | 607 | 820 | 857 | 838 | 649 | 372 | 288 |
| Cash flow | |||||||
| Cash from operations | 184 | 255 | 334 | 354 | 220 | 110 | 144 |
| Cash from investing | (344) | (139) | (274) | (210) | (147) | (61.59) | (130) |
| Cash from financing | 84.57 | (48.52) | (74.97) | (81.23) | (56.51) | (37.45) | (25.67) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 468 | 456 | 395 | 331 | 341 | 358 | 353 | 313 |
| Revenue growth (YoY) | +37.3% | +27.2% | +11.9% | +5.9% | -1.8% | -6.9% | - | - |
| Other income | 4.38 | 5.52 | 7.74 | 4.99 | 7.05 | 9.02 | 8.03 | 7.86 |
| EBITDA | 102 | 116 | 94.25 | 56.67 | 59.81 | 54.69 | 59.67 | 45.71 |
| EBITDA margin | +21.7% | +25.4% | +23.9% | +17.1% | +17.6% | +15.3% | +16.9% | +14.6% |
| Depreciation | 15.32 | 13.78 | 13.95 | 14.17 | 14.28 | 13.97 | 12.90 | 11.88 |
| Interest | 1.34 | 1.41 | 2.18 | 1.51 | 0.96 | 0.73 | 0.86 | 0.80 |
| Profit before tax | 89.30 | 106 | 85.86 | 45.98 | 51.62 | 49.01 | 53.94 | 40.89 |
| Tax | 21.83 | 28.09 | 21.09 | 15.23 | 14.53 | 12.49 | 13.49 | 9.75 |
| Net profit | 67.47 | 78.12 | 64.77 | 30.75 | 37.09 | 36.52 | 40.45 | 31.14 |
| EPS (βΉ) | 20.76 | 23.13 | 19.99 | 9.49 | 10.67 | 11.73 | 12.36 | 10.24 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,292 | 1,274 | 1,338 | 1,726 | 1,921 | 1,228 | 919 |
| Revenue growth | +1.4% | -4.8% | -22.5% | -10.1% | +56.4% | +33.6% | - |
| EBITDA | 247 | 226 | 247 | 330 | 441 | 327 | 180 |
| EBITDA margin | +19.1% | +17.8% | +18.4% | +19.1% | +23.0% | +26.6% | +19.6% |
| Profit before tax | 227 | 209 | 232 | 305 | 423 | 310 | 154 |
| Net profit | 165 | 156 | 171 | 226 | 308 | 231 | 114 |
| Net profit margin | +12.8% | +12.3% | +12.8% | +13.1% | +16.0% | +18.8% | +12.4% |
| EPS (βΉ) | 51.09 | 48.21 | 52.87 | 70.23 | 95.04 | 71.51 | 35.11 |
| Balance sheet | |||||||
| Total assets | 1,795 | 1,659 | 1,540 | 1,404 | 1,195 | 1,043 | 934 |
| Net worth | 1,785 | 1,655 | 1,534 | 1,400 | 1,192 | 897 | 668 |
| Total debt | 0.37 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 102 |
| Cash & bank | 271 | 243 | 206 | 161 | 48.12 | 17.66 | 7.26 |
| Net working capital | 667 | 648 | 635 | 623 | 466 | 286 | 225 |
| Cash flow | |||||||
| Cash from operations | 200 | 224 | 217 | 187 | 176 | 93.92 | 148 |
| Cash from investing | (129) | (179) | (190) | (155) | (142) | (86.55) | (130) |
| Cash from financing | (35.74) | (37.52) | (34.58) | (22.17) | (20.00) | 3.02 | (30.84) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 428 | 423 | 362 | 301 | 309 | 319 | 322 | 299 |
| Revenue growth (YoY) | +38.4% | +32.4% | +12.5% | +0.7% | -3.4% | -4.0% | - | - |
| Other income | 6.40 | 6.17 | 8.40 | 5.37 | 6.98 | 7.27 | 5.82 | 5.45 |
| Total expenses | 331 | 319 | 276 | 246 | 259 | 263 | 264 | 248 |
| EBITDA | 96.96 | 103 | 86.08 | 54.70 | 50.01 | 56.47 | 58.05 | 51.66 |
| EBITDA margin | +22.7% | +24.5% | +23.8% | +18.2% | +16.2% | +17.7% | +18.1% | +17.3% |
| Depreciation | 12.71 | 11.54 | 11.41 | 11.61 | 11.52 | 11.06 | 10.36 | 9.85 |
| Interest | 0.22 | 0.27 | 1.04 | 0.47 | 0.43 | 0.34 | 0.47 | 0.41 |
| Profit before tax | 90.43 | 97.82 | 82.03 | 47.99 | 45.04 | 52.34 | 53.04 | 46.85 |
| Tax | 21.71 | 25.67 | 20.17 | 15.58 | 13.59 | 12.54 | 13.43 | 11.15 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 468 | 456 | 395 | 331 | 341 | 358 | 353 | 313 |
| Revenue growth (YoY) | +37.3% | +27.2% | +11.9% | +5.9% | -1.8% | -6.9% | - | - |
| Other income | 4.38 | 5.52 | 7.74 | 4.99 | 7.05 | 9.02 | 8.03 | 7.86 |
| EBITDA | 102 | 116 | 94.25 | 56.67 | 59.81 | 54.69 | 59.67 | 45.71 |
| EBITDA margin | +21.7% | +25.4% | +23.9% | +17.1% | +17.6% | +15.3% | +16.9% | +14.6% |
| Depreciation | 15.32 | 13.78 | 13.95 | 14.17 | 14.28 | 13.97 | 12.90 | 11.88 |
| Interest | 1.34 | 1.41 | 2.18 | 1.51 | 0.96 | 0.73 | 0.86 | 0.80 |
| Profit before tax | 89.30 | 106 | 85.86 | 45.98 | 51.62 | 49.01 | 53.94 | 40.89 |
| Tax | 21.83 | 28.09 | 21.09 | 15.23 | 14.53 | 12.49 | 13.49 | 9.75 |
| Net profit | 67.47 | 78.12 | 64.77 | 30.75 | 37.09 | 36.52 | 40.45 | 31.14 |
| EPS (βΉ) | 20.76 | 23.13 | 19.99 | 9.49 | 10.67 | 11.73 | 12.36 | 10.24 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,425 | 1,397 | 1,642 | 2,355 | 2,323 | 1,311 | 936 |
| Revenue growth | +2.0% | -14.9% | -30.3% | +1.4% | +77.1% | +40.2% | - |
| Other income | 28.81 | 33.20 | 29.64 | 15.25 | 14.72 | 6.07 | 5.01 |
| Total expenses | 1,160 | 1,165 | 1,318 | 1,746 | 1,700 | 938 | 755 |
| Employee cost | 84.11 | 79.86 | 82.27 | 85.21 | 96.64 | 33.56 | 34.07 |
| EBITDA | 265 | 232 | 324 | 609 | 623 | 373 | 181 |
| EBITDA margin | +18.6% | +16.6% | +19.7% | +25.9% | +26.8% | +28.5% | +19.3% |
| Depreciation | 56.38 | 48.44 | 45.37 | 45.57 | 42.00 | 34.41 | 31.62 |
| Interest | 5.37 | 3.70 | 6.44 | 11.97 | 17.10 | 18.29 | 23.03 |
| Profit before tax | 232 | 213 | 302 | 567 | 578 | 327 | 131 |
| Tax | 63.33 | 54.63 | 69.25 | 161 | 160 | 83.10 | 33.63 |
| Net profit | 167 | 157 | 204 | 324 | 368 | 237 | 105 |
| Net profit margin | +11.7% | +11.3% | +12.5% | +13.7% | +15.9% | +18.1% | +11.2% |
| EPS (βΉ) | 51.60 | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 |
| Reserves & surplus | 1,970 | 1,839 | 1,715 | 1,548 | 1,243 | 888 | 652 |
| Shareholders' funds (net worth) | 1,976 | 1,845 | 1,722 | 1,554 | 1,250 | 894 | 658 |
| Minority interest | 175 | 173 | 171 | 144 | 65.01 | 15.53 | 10.23 |
| Secured loans | 133 | 10.61 | 19.70 | 57.57 | 101 | 123 | 256 |
| Unsecured loans | 0.37 | 0.42 | 0.00 | 0.00 | 0.00 | 4.00 | 4.00 |
| Total debt | 133 | 11.03 | 19.70 | 57.57 | 101 | 127 | 260 |
| Total liabilities | 2,295 | 2,033 | 1,919 | 1,760 | 1,420 | 1,058 | 945 |
| Assets | |||||||
| Gross block | 1,511 | 1,417 | 1,264 | 1,104 | 969 | 790 | 786 |
| Net block | 1,043 | 1,003 | 896 | 781 | 681 | 543 | 573 |
| Capital work in progress | 512 | 238 | 205 | 113 | 141 | 173 | 46.27 |
| Investments | 0.00 | 0.00 | 0.00 | 72.65 | 0.00 | 0.00 | 47.50 |
| Inventories | 247 | 274 | 287 | 303 | 222 | 110 | 109 |
| Sundry debtors | 346 | 275 | 319 | 378 | 588 | 306 | 207 |
| Cash & bank balances | 271 | 354 | 340 | 236 | 51.56 | 19.64 | 8.81 |
| Loans & advances | 76.56 | 38.32 | 50.89 | 43.23 | 45.03 | 142 | 88.05 |
| Total current assets | 941 | 941 | 997 | 960 | 907 | 577 | 413 |
| Total current liabilities | 334 | 121 | 140 | 122 | 258 | 205 | 125 |
| Net working capital | 607 | 820 | 857 | 838 | 649 | 372 | 288 |
| Total assets | 2,295 | 2,033 | 1,919 | 1,760 | 1,420 | 1,058 | 945 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 149 | 81.20 | 96.36 | 33.13 | 17.32 | 8.81 | 20.40 |
| Net cash from operating activities | 184 | 255 | 334 | 354 | 220 | 110 | 144 |
| Net cash from investing activities | (344) | (139) | (274) | (210) | (147) | (61.59) | (130) |
| Net cash from financing activities | 84.57 | (48.52) | (74.97) | (81.23) | (56.51) | (37.45) | (25.67) |
| Net change in cash | (74.97) | 67.69 | (15.16) | 63.23 | 15.80 | 10.83 | (11.59) |
| Closing cash | 271 | 354 | 340 | 236 | 51.56 | 19.64 | 8.81 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +2.0% | -14.9% | -30.3% | +1.4% | +77.1% | +40.2% | - |
| EBITDA growth | +14.3% | -28.3% | -46.9% | -2.2% | +66.8% | +106.5% | - |
| PBT growth | +9.1% | -29.3% | -46.8% | -2.0% | +77.1% | +149.1% | -20.6% |
| Net income growth | +6.1% | -23.0% | -36.8% | -12.1% | +55.1% | +126.7% | - |
| Revenue CAGR (3Y) | -15.4% | -15.6% | +7.8% | +36.0% | +35.1% | +15.1% | +11.8% |
| EBITDA CAGR (3Y) | -24.2% | -28.0% | -4.6% | +49.9% | +47.7% | +27.0% | +6.6% |
| Profitability & leverage | |||||||
| Net income margin | +11.9% | +11.4% | +14.2% | +17.2% | +18.0% | +18.6% | +10.4% |
| Return on capital employed | +12.0% | +12.0% | +18.3% | +39.0% | +49.7% | +34.9% | +17.6% |
| Return on net worth | +8.9% | +8.9% | +14.2% | +28.9% | +39.0% | +31.4% | +15.8% |
| Debt / equity | 0.04 | 0.01 | 0.02 | 0.06 | 0.11 | 0.25 | 0.40 |
| Long-term debt / equity | 0.02 | 0.00 | 0.01 | 0.03 | 0.07 | 0.13 | 0.16 |
| Interest cover | 2.57 | 2.01 | 2.31 | 2.12 | 2.94 | 5.40 | 15.44 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.97 | 1.04 | 1.39 | 2.27 | 2.64 | 1.66 | 1.45 |
| Inventory turnover | 5.47 | 4.98 | 5.57 | 8.97 | 13.98 | 11.99 | 6.88 |
| Debtors turnover | 4.59 | 4.70 | 4.71 | 4.88 | 5.20 | 5.11 | 5.00 |
| EPS (βΉ) | 51.60 | 48.62 | 63.22 | 100.47 | 113.71 | 73.51 | 32.34 |
| Dividend per share (βΉ) | 11.00 | 11.00 | 11.00 | 10.00 | 6.00 | 4.00 | 3.20 |
| Book value per share (βΉ) | 610.00 | 569.44 | 531.42 | 479.69 | 385.74 | 276.04 | 203.12 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 428 | 423 | 362 | 301 | 309 | 319 | 322 | 299 |
| Revenue growth (YoY) | +38.4% | +32.4% | +12.5% | +0.7% | -3.4% | -4.0% | - | - |
| Other income | 6.40 | 6.17 | 8.40 | 5.37 | 6.98 | 7.27 | 5.82 | 5.45 |
| Total expenses | 331 | 319 | 276 | 246 | 259 | 263 | 264 | 248 |
| EBITDA | 96.96 | 103 | 86.08 | 54.70 | 50.01 | 56.47 | 58.05 | 51.66 |
| EBITDA margin | +22.7% | +24.5% | +23.8% | +18.2% | +16.2% | +17.7% | +18.1% | +17.3% |
| Depreciation | 12.71 | 11.54 | 11.41 | 11.61 | 11.52 | 11.06 | 10.36 | 9.85 |
| Interest | 0.22 | 0.27 | 1.04 | 0.47 | 0.43 | 0.34 | 0.47 | 0.41 |
| Profit before tax | 90.43 | 97.82 | 82.03 | 47.99 | 45.04 | 52.34 | 53.04 | 46.85 |
| Tax | 21.71 | 25.67 | 20.17 | 15.58 | 13.59 | 12.54 | 13.43 | 11.15 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,292 | 1,274 | 1,338 | 1,726 | 1,921 | 1,228 | 919 |
| Revenue growth | +1.4% | -4.8% | -22.5% | -10.1% | +56.4% | +33.6% | - |
| Other income | 28.02 | 22.78 | 20.90 | 9.76 | 18.39 | 12.03 | 10.26 |
| Total expenses | 1,044 | 1,047 | 1,091 | 1,397 | 1,480 | 901 | 739 |
| Employee cost | 77.14 | 72.96 | 72.35 | 80.25 | 93.48 | 31.42 | 32.71 |
| EBITDA | 247 | 226 | 247 | 330 | 441 | 327 | 180 |
| EBITDA margin | +19.1% | +17.8% | +18.4% | +19.1% | +23.0% | +26.6% | +19.6% |
| Depreciation | 45.60 | 38.37 | 33.65 | 31.26 | 29.17 | 23.34 | 24.18 |
| Interest | 2.28 | 1.86 | 2.18 | 2.73 | 7.04 | 5.33 | 12.13 |
| Profit before tax | 227 | 209 | 232 | 305 | 423 | 310 | 154 |
| Tax | 61.88 | 52.76 | 60.31 | 77.83 | 115 | 78.26 | 39.96 |
| Net profit | 165 | 156 | 171 | 226 | 308 | 231 | 114 |
| Net profit margin | +12.8% | +12.3% | +12.8% | +13.1% | +16.0% | +18.8% | +12.4% |
| EPS (βΉ) | 51.09 | 48.21 | 52.87 | 70.23 | 95.04 | 71.51 | 35.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 | 6.48 |
| Reserves & surplus | 1,778 | 1,649 | 1,528 | 1,394 | 1,186 | 891 | 661 |
| Shareholders' funds (net worth) | 1,785 | 1,655 | 1,534 | 1,400 | 1,192 | 897 | 668 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 102 |
| Unsecured loans | 0.37 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.37 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 | 102 |
| Total liabilities | 1,795 | 1,659 | 1,540 | 1,404 | 1,195 | 1,043 | 934 |
| Assets | |||||||
| Gross block | 1,274 | 1,179 | 1,033 | 882 | 752 | 572 | 569 |
| Net block | 883 | 833 | 724 | 604 | 495 | 344 | 363 |
| Capital work in progress | 203 | 154 | 143 | 73.74 | 141 | 173 | 46.27 |
| Investments | 66.00 | 66.00 | 66.00 | 128 | 66.00 | 66.00 | 114 |
| Inventories | 216 | 251 | 263 | 267 | 203 | 95.93 | 92.18 |
| Sundry debtors | 296 | 246 | 262 | 260 | 436 | 272 | 191 |
| Cash & bank balances | 271 | 243 | 206 | 161 | 48.12 | 17.66 | 7.26 |
| Loans & advances | 21.23 | 22.42 | 33.25 | 23.10 | 15.57 | 100 | 55.23 |
| Total current assets | 804 | 762 | 764 | 711 | 702 | 486 | 346 |
| Total current liabilities | 137 | 114 | 128 | 88.30 | 237 | 200 | 120 |
| Net working capital | 667 | 648 | 635 | 623 | 466 | 286 | 225 |
| Total assets | 1,795 | 1,659 | 1,540 | 1,404 | 1,195 | 1,043 | 934 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 38.49 | 30.90 | 39.27 | 29.71 | 15.37 | 7.26 | 20.36 |
| Net cash from operating activities | 200 | 224 | 217 | 187 | 176 | 93.92 | 148 |
| Net cash from investing activities | (129) | (179) | (190) | (155) | (142) | (86.55) | (130) |
| Net cash from financing activities | (35.74) | (37.52) | (34.58) | (22.17) | (20.00) | 3.02 | (30.84) |
| Net change in cash | 35.13 | 7.59 | (8.36) | 9.55 | 14.35 | 10.39 | (13.10) |
| Closing cash | 271 | 243 | 206 | 161 | 48.12 | 17.66 | 7.26 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +1.4% | -4.8% | -22.5% | -10.1% | +56.4% | +33.6% | - |
| EBITDA growth | +9.2% | -8.2% | -25.2% | -25.3% | +35.0% | +81.7% | - |
| PBT growth | +8.8% | -9.8% | -24.2% | -27.8% | +36.5% | +101.7% | -7.4% |
| Net income growth | +5.9% | -8.7% | -24.3% | -26.6% | +33.3% | +103.2% | - |
| Revenue CAGR (3Y) | -9.2% | -12.8% | +2.9% | +23.4% | +26.5% | +12.6% | +11.3% |
| EBITDA CAGR (3Y) | -9.1% | -19.9% | -9.0% | +22.4% | +31.6% | +21.5% | +5.9% |
| Profitability & leverage | |||||||
| Net income margin | +12.8% | +12.3% | +12.8% | +13.2% | +16.0% | +18.9% | +12.4% |
| Return on capital employed | +13.3% | +13.2% | +15.9% | +23.7% | +38.4% | +31.9% | +19.2% |
| Return on net worth | +9.6% | +9.8% | +11.7% | +17.6% | +29.5% | +29.6% | +18.3% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.16 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 1.13 | 0.99 | 1.02 | 0.92 | 1.71 | 1.76 | 7.80 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.05 | 1.15 | 1.40 | 2.11 | 2.90 | 2.15 | 1.72 |
| Inventory turnover | 5.54 | 4.96 | 5.05 | 7.35 | 12.87 | 13.05 | 7.83 |
| Debtors turnover | 4.77 | 5.02 | 5.12 | 4.96 | 5.42 | 5.30 | 5.13 |
| EPS (βΉ) | 51.09 | 48.21 | 52.87 | 70.23 | 95.04 | 71.51 | 35.11 |
| Dividend per share (βΉ) | 11.00 | 11.00 | 11.00 | 10.00 | 6.00 | 4.00 | 3.20 |
| Book value per share (βΉ) | 550.90 | 510.86 | 473.56 | 432.19 | 368.01 | 276.97 | 206.06 |
Web traffic of Balaji Amines
The website of Balaji Amines (balajiamines.com) receives about 3K visits a month.
- Monthly visits3K
▼ 38.9% vs previous month
Websites whose visitors overlap most with Balaji Amines. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| qvchemicals.com | 100% | View details | |||
| indoaminesltd.com | 96% | 2.4K | #7,070,897 | View details | |
| amines.com | 96% | 4.1K | #4,568,844 | View details | |
| lookchem.com | 96% | 222.7K | #195,131 | View details | |
| alkylamines.com | 96% | 10.6K | #2,201,718 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 8 similar websites and full traffic analytics for Balaji Amines
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Core & Diversified Chemicals
3 companies that operate in the same segment as Balaji Amines (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate | 1979 | Pune, Maharashtra, India | USD 1.21 B | 1,020 | ||
Specialty chemicals are manufactured through integrated R&D and production processes. | 2023 | Bengaluru, Karnataka, India | USD 72.97 M | USD 23.86 M | ||
Manufactures coal tar and basic industrial chemicals. | 1987 | Kolkata, West Bengal, India | USD 24 M | USD 515.01 M | 1,161 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Balaji Amines
Complete news archive for Balaji Amines
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Balaji Amines
Balaji Amines was founded in 1988.
Balaji Amines is headquartered in Solapur, India. It is registered at Solapur, Maharashtra, India.
Balaji Amines has 21 employees.
The primary company behind Balaji Amines, Balaji Amines Limited, reported revenue of βΉ1,454 Cr for FY 2026, up 2% year on year.
Balaji Amines was established in 1988 and is headquartered in Solapur, India. Operations focus on the chemical manufacturing sector, where methylamines, ethylamines, derivatives of specialty chemicals, and pharmaceutical excipients are produced. Downstream products are developed for applications in the pharmaceutical and pesticides industries, supporting various industrial needs through diversified chemical outputs.
Balaji Amines offers Amines, Derivatives, Speciality Chemicals, and Pharma Excipients.
Yes, Balaji Amines is publicly traded on NSE under the ticker symbol BALAMINES.
Balaji Amines is associated with 2 legal entities: Balaji Amines Limited, Balaji Speciality Fine Chem Products Llp.
The legal entities of Balaji Amines currently have 9 directors, including Rajeshwar Reddy Nomula, Ram Reddy Dundurapu, Ande Srinivas Reddy and others.
